Clinical Trials
2 trialsNCT07557914 2026-06-03
Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes
First Hospital of China Medical University
Phase 2 Not yet recruiting
NCT05124405 2026-05-20
Monitoring Your Exercise-related Metrics Over Time Via Wearable Electronic Devices
M.D. Anderson Cancer Center
Phase NA Active not recruiting